Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 1;71(6):437-444.
doi: 10.1097/MAT.0000000000002412. Epub 2025 Mar 6.

Surgical Intervention for Outflow Graft Obstruction in Patients With Magnetically Levitated Centrifugal-Flow Left Ventricular Assist Devices

Krish C Dewan  1 , Alejandro Alvarez Lobo  1 , Jacob N Schroder  1 , Jeffrey E Keenan  1 , Adam D DeVore  2 , Stuart D Russell  2 , Carmelo A Milano  1
Affiliations

Surgical Intervention for Outflow Graft Obstruction in Patients With Magnetically Levitated Centrifugal-Flow Left Ventricular Assist Devices

Krish C Dewan et al. ASAIO J. .

Abstract

Outflow graft obstruction (OGO) is an under-reported but severe complication after insertion of magnetically levitated centrifugal-flow left ventricular assist devices (LVADs). The optimal treatment and long-term outcomes have not been well-described. We report a retrospective single high-volume center's experience with surgical exploration for OGO from June 2019 to October 2023. Outflow graft obstruction was identified in 19 LVAD recipients from a total experience of 550 LVAD implants (3.3%). Median time of LVAD support to development of OGO was 32.5 months (interquartile range [IQR], 28-47.5). Low-flow alarms were the most common presentation, followed by dyspnea on exertion, and syncope. Computed tomography angiography (CTA) and echocardiography were the most common diagnostic modalities. Aortic valve opening with every beat and worsened mitral insufficiency were both more common at presentation compared to prior echocardiographic studies. Surgical excision of the bend relief (BR) and evacuation of proteinaceous material between the BR and the outflow graft immediately improved hemodynamics and LVAD function. There were no in-hospital mortalities, and all patients were discharged home after a median length of stay of 9 days (IQR, 10-21). All but four patients were alive at median follow-up 21 months. Thirteen of the 19 patients were readmitted a total of 50 times, none for recurrent OGO.

Keywords: Heartmate; LVAD; heart failure; outflow graft obstruction.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to report.

References

    1. Mehra MR, Goldstein DJ, Cleveland JC, et al.: Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA. 328: 1233–1242, 2022.
    1. Agrawal A, Alexy T, Kamioka N, et al.: Outflow graft obstruction after left ventricular assist device implantation: A retrospective, single-centre case series. ESC Heart Fail. 8: 2349–2353, 2021.
    1. Milwidsky A, Villela MA, Wiley J, et al.: Outflow graft obstruction in patients with the HM 3 LVAD: A percutaneous approach. Catheter Cardiovasc Interv. 98: 1383–1390, 2021.
    1. Kaku Y, Naka Y, Witer L, et al.: Late inflow or outflow obstruction requiring surgical intervention after HeartMate 3 left ventricular assist device insertion. Interact Cardiovasc Thorac Surg. 31: 626–628, 2020.
    1. Jain SS, Clerkin KJ, Anstey DE, et al.: Outflow graft narrowing of the HeartMate 3 left ventricular assist device. Ann Thorac Surg. 115: 1282–1288, 2023.

LinkOut - more resources